Posted On: 08/24/2015 10:51:39 AM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Quote:
Last week United Therapeutics Corporation agreed to sell its Priority Review Voucher to AbbVie for $350 Million
- See more at: http://cellceutix.com/cellceutix-requesting-m...AAKXa.dpuf
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)